Canton Strategic Holdings, Inc. (CNTN)
1.68
-0.02
(-0.88%)
USD |
NASDAQ |
Oct 19, 15:47
Canton Strategic Holdings Net Income (Quarterly) : -17.95M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.95M |
| March 31, 2026 | -47.34M |
| December 31, 2025 | -29.42M |
| September 30, 2025 | -2.102M |
| June 30, 2025 | -1.433M |
| March 31, 2025 | -2.542M |
| December 31, 2024 | -3.821M |
| September 30, 2024 | -3.796M |
| June 30, 2024 | -2.325M |
| March 31, 2024 | -2.256M |
| December 31, 2023 | -2.474M |
| September 30, 2023 | -1.820M |
| June 30, 2023 | -2.337M |
| Date | Value |
|---|---|
| March 31, 2023 | -2.688M |
| December 31, 2022 | -1.766M |
| September 30, 2022 | -2.128M |
| June 30, 2022 | -1.637M |
| March 31, 2022 | -2.942M |
| December 31, 2021 | 2.453M |
| September 30, 2021 | -0.8534M |
| June 30, 2021 | -1.556M |
| March 31, 2021 | -2.250M |
| September 30, 2020 | -0.4141M |
| June 30, 2020 | -0.2414M |
| March 31, 2020 | -0.466M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.496M |
| Total Expenses (Quarterly) | 19.45M |
| EPS Diluted (Quarterly) | -0.0888 |
| Enterprise Value | 93.74M |
| Profit Margin (Quarterly) | -1.20K% |
| Earnings Yield | -86.08% |
| Normalized Earnings Yield | -53.80 |